Structure-based organic synthesis of unnatural aeruginosin hybrids as potent inhibitors of thrombin

被引:28
|
作者
Hanessian, Stephen
Ersmark, Karolina
Wang, Xiaotian
Del Valle, Juan R.
Blomberg, Niklas
Xue, Yafeng
Fjellstrom, Ola
机构
[1] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada
[2] AstraZeneca R&D, Global Compound Sci, S-43183 Molndal, Sweden
[3] AstraZeneca R&D, Struct Chem Lab, S-43183 Molndal, Sweden
[4] AstraZeneca R&D, Med Chem, S-43183 Molndal, Sweden
基金
加拿大自然科学与工程研究理事会;
关键词
thrombin inhibition; aeruginosin mimics; chloroleucine;
D O I
10.1016/j.bmcl.2007.03.075
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Based on X-ray crystallographic data of complexes of chlorodysinosin A with the enzyme thrombin, a series of analogs were synthesized varying the nature of the P-1, P-2, and P-3 pharmacophoric sites and the central octahydroindole carboxyamide core. In general, introduction of a hydrophobic substituent on the D-leucine amide residue dramatically improved the inhibition of the enzyme. This is rationalized based on a better fit of the P-3 subunit in the hydrophobic S-3 enzyme site. Single digit nanomolar inhibition expressed as IC50 was observed for several analogs. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3480 / 3485
页数:6
相关论文
共 50 条
  • [1] Structure-based design of novel potent nonpeptide thrombin inhibitors
    Hauel, NH
    Nar, H
    Priepke, H
    Ries, U
    Stassen, JM
    Wienen, W
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) : 1757 - 1766
  • [2] Structure-based design of thrombin inhibitors
    Pfau, R
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2003, 6 (04) : 437 - 450
  • [3] Structure-based design of a potent chimeric thrombin inhibitor
    Morenweiser, R
    Auerswald, EA
    vandeLocht, A
    Fritz, H
    Sturzebecher, J
    Stubbs, MT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) : 19938 - 19942
  • [4] Structure-based design and synthesis of novel thrombin inhibitors based on phosphinic peptide mimetics
    Li, M
    Lin, ZL
    Johnson, ME
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) : 1957 - 1962
  • [5] Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors
    Choi, Jun Yong
    Fuerst, Rita
    Knapinska, Anna M.
    Taylor, Alexander B.
    Smith, Lyndsay
    Cao, Xiaohang
    Hart, P. John
    Fields, Gregg B.
    Roush, William R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5816 - 5825
  • [6] Structure-based discovery of potent inhibitors of Axl: design, synthesis, and biological evaluation
    Wu, Shuang
    Liao, Min
    Li, Minxiong
    Sun, Mingming
    Xi, Ning
    Zeng, Youlin
    RSC MEDICINAL CHEMISTRY, 2022, 13 (10): : 1246 - 1264
  • [7] DISCOVERY OF TRIKETONE-QUINOXALINE HYBRIDS AS POTENT HPPD INHIBITORS USING STRUCTURE-BASED DRUG DESIGN
    Baifeng ZHENG
    Yaochao YAN
    Can FU
    Guangyi HUANG
    Long ZHAO
    Qiong CHEN
    Renyu QU
    Guangfu YANG
    Frontiers of Agricultural Science and Engineering, 2022, 9 (01) : 133 - 145
  • [8] DISCOVERY OF TRIKETONE-QUINOXALINE HYBRIDS AS POTENT HPPD INHIBITORS USING STRUCTURE-BASED DRUG DESIGN
    Zheng, Baifeng
    Yan, Yaochao
    Fu, Can
    Huang, Guangyi
    Zhao, Long
    Chen, Qiong
    Qu, Renyu
    Yang, Guangfu
    FRONTIERS OF AGRICULTURAL SCIENCE AND ENGINEERING, 2022, 9 (01) : 133 - 145
  • [9] Molecular recognition at the thrombin active site: Structure-based design and synthesis of potent and selective thrombin inhibitors and the x-ray crystal structures of two thrombin-inhibitor complexes
    Obst, U
    Banner, DW
    Weber, L
    Diederich, F
    CHEMISTRY & BIOLOGY, 1997, 4 (04): : 287 - 295
  • [10] Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitors
    Futamura-Takahashi, Junko
    Tanaka, Taisaku
    Sugawara, Hajime
    Iwashita, Shinzo
    Imajo, Seiichi
    Oyama, Yoshiaki
    Muto, Tsuyoshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (02) : 188 - 192